This targeting approach, which is independent of an effect on hypertension, provides greater protection for the heart than kidneys during diabetes, suggesting that the pathological effects of myeloid MR signalling are more critical to the development of cardiac disease than kidney disease during diabetes. The gene discussed is NR3C2; the disease is kidney disorder.